Temporary occlusion of the hypogastric artery to reduce blood loss associated with laparoscopic myomectomy

ISRCTN ISRCTN66897343
DOI https://doi.org/10.1186/ISRCTN66897343
Submission date
27/06/2023
Registration date
03/07/2023
Last edited
07/09/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Uterine leiomyomas, or uterine fibroids, are benign tumors in the pelvic region that are commonly found in women. For women of reproductive age experiencing symptoms from these tumors, laparoscopic myomectomy (LM) is the preferred treatment option in which myomas are surgically removed through small incisions in the abdomen. In this study, the authors propose that combining LM with blocking blood flow of arteries in the pelvis, or temporary occlusion of the hypogastric artery (TOHA) using vascular clips, can reduce uterine blood flow during surgery and effectively decrease surgery-related blood loss.

Who can participate?
Adult women aged 18-49 years old diagnosed with intramural uterine leiomyomas larger than 4 cm in diameter, who preferred LM and wished to preserve fertility.

What does the study involve?
Participants were randomized into two parallel groups:
1. Patients undergoing standard LM
2. Patients undergoing LM with TOHA clipping.

What are the possible benefits and risks of participating?
The main benefits regard reduced surgery-associated blood loss. There are no foreseen risks associated with the intervention.

Where is the study run from?
Ob-Gyn Clinic of Emergency Municipal Clinical Hospital in Timisoara, Romania. The clinic is affiliated with "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

When is the study starting and how long is it expected to run for?
January 2018 to December 2021

Who is funding the study?
"Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania

Who is the main contact?
Prof Laurentiu Pirtea (Principal investigator), pirtea.laurentiu@umft.ro
Dr Cristina Secosan, secosan.cristina@umft.ro

Contact information

Prof Laurentiu Pirtea
Principal Investigator

Victor Babeș University of Medicine and Pharmacy Timișoara
Piata Eftimie Murgu 2
Timisoara
300041
Romania

ORCiD logoORCID ID 0000-0002-4398-2492
Phone +40756162282
Email pirtea.laurentiu@umft.ro
Dr Diana Lungeanu
Scientific

Victor Babeș University of Medicine and Pharmacy Timișoara
Piata Eftimie Murgu 2
Timisoara
300041
Romania

ORCiD logoORCID ID 0000-0002-0274-1377
Phone +40722488775
Email dlungeanu@umft.ro
Dr Cristina Secosan
Scientific

Victor Babeș University of Medicine and Pharmacy Timișoara
Piata Eftimie Murgu 2
Timisoara
300041
Romania

ORCiD logoORCID ID 0000-0003-1355-3790
Phone +40762647210
Email secosan.cristina@umft.ro

Study information

Study designProof-of-concept single-center interventional single-blinded randomized controlled trial
Primary study designInterventional
Secondary study designRandomised parallel trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet 43858_PIS.pdf
Scientific titleInvestigation of bilateral Temporary Occlusion of the Hypogastric Artery in women undergoing laparoscopic myomectomy to minimize consequences of blood loss
Study acronymTOHAs
Study objectivesCombining laparoscopic myomectomy with a bilateral temporary occlusion of the hypogastric artery (TOHA) using vascular clips minimizes uterine blood flow during surgery and can significantly reduce surgery-associated blood loss.
Ethics approval(s)

Approved 10/12/2018, Human Ethical Committee of “Victor Babes” University of Medicine and Pharmacy (Piata Eftimie Murgu 2, Timisoara, 300041, Romania; +40 256466001; cecs@umft.ro), ref: 44/10.12.2018

Health condition(s) or problem(s) studiedLaparoscopic myomectomy in adult women
InterventionCombining laparoscopic myomectomy with temporary bilateral occlusion of the hypogastric artery.

Study arms:
There are two arms that include participants who are randomly allocated to the following interventions:
LM − laparoscopic myomectomy with no hypogastric artery clipping
LM + TOHA − laparoscopic myomectomy with temporary occlusion of the hypogastric artery

Method of randomization:
Randomization was single-blind and performed with the R package "blockrand" version 1.5.

Intervention providers:
All surgical procedures are performed by a single and highly proficient surgeon with over a decade of experience in laparoscopic surgery.

Modes of delivery
Prior to the surgery, neither Gonadotropin-Releasing Hormone (GnRH) agonists nor any intra-operative hemostatic drugs, such as vasopressin injections, are employed. Before initiating surgical procedures, general anesthesia was induced concomitantly with orotracheal intubation. Abdominal access was obtained via a direct trocar entry technique. CO2 insufflation was used to create a pneumoperitoneum with a low intra-abdominal pressure of up to 12 mmHg. A 10 mm trocar was positioned on the median line, 8 cm away from the umbilicus, while two 5 mm trocars are situated on each side of the lower abdomen. The patient was then reclined in a Trendelenburg position. The parietal peritoneum was incised below the lumbo-ovarian ligament. The ureter and anterior trunk of the hypogastric artery are identified in the area where these two structures run parallel. The ureter and hypogastric artery are identified using blunt dissection. A metallic clip was then placed on the anterior trunk of the hypogastric artery, cranially to the uterine artery emergence.

The uterine wall was incised, and the myoma/s are located and then removed using traction and countertraction maneuvers. Next, in-bag morcellation was used to remove the leiomyoma/s. The uterine wall was sutured with a double-layer stitch, utilizing a 29 mm, 3/8 circle needle, and Vicryl 2.0 thread. Once the uterine wall had been closed, hemostatic clips are gently removed by traction using atraumatic Johan fenestrated forceps.

Location where the intervention occurred
All surgical interventions are performed within the facilities of the Ob-Gyn Clinic of Emergency Municipal Clinical Hospital in Timisoara, Romania. The clinic is a tertiary referral hospital and is affiliated with "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
Intervention typeProcedure/Surgery
Primary outcome measureTotal hemoglobin concentration (g/dL) measured using a blood gas analyzer system (carried out in the CO-oximetry module) within the hospital laboratory before and immediately after the surgery
Secondary outcome measures1. Required iron perfusion measured using the quantity of iron administered by intravenous infusion after surgery decided by the consultant based on ferritin concentration < 100 µg.I-1 after surgery
2. Required postoperative blood transfusion measured using blood testing and determined by the consultant based on a hemoglobin level of 70-80 g.I-1 measured after surgery
3. Anemia measured using blood testing and diagnosed based on hemoglobin less than 120 g/L (12 g/dL) as a dichotomous variable after surgery
4. Overall operative time measured using medical records as the time elapsed from the initial incision to final skin closure after surgery
5. Twelve-month post-operative spontaneous pregnancy measured using medical records as any pregnancy recorded within 12 months after laparoscopic myomectomy, without assisted reproductive measures at one timepoint at the end of the study
6. Hospital re-admission rate of participants in the trial who return to the hospital within seven days of discharge after laparoscopic myomectomy measured using medical records at one timepoint at the end of the study
7. Reports of death, including in-hospital death, or within 14 days of discharge after laparoscopic myomectomy, measured using medical records at one timepoint at the end of the study
Overall study start date01/01/2018
Completion date31/12/2021

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit49 Years
SexFemale
Target number of participants62
Total final enrolment60
Key inclusion criteria1. Aged between 18 and 49 years old
2. Preference for laparoscopic myomectomy and their desire to preserve fertility
3. Intramural uterine leiomyomas greater than 4 cm in diameter
Key exclusion criteria1. Patients who did not agree to the enrollment or did not pass inclusion criteria (such as: age over 50, no preference for fertility preservation, personal option for hysterectomy)
2. Other types of myomas (such as submucosal or sub-serosal location), or intramural myomas under 4 cm which did not have an impact on the uterine cavity
3. Suspected of malignancy
Date of first enrolment01/01/2019
Date of final enrolment31/12/2020

Locations

Countries of recruitment

  • Romania

Study participating centre

Emergency Municipal Clinical Hospital
Strada Hector 2A
Timisoara
300231
Romania

Sponsor information

Victor Babeș University of Medicine and Pharmacy Timișoara
University/education

Piata Eftimie Murgu 2
Timisoara
300041
Romania

Phone +40256204400
Email scr-stin@umft.ro
Website https://www.umft.ro
ROR logo "ROR" https://ror.org/00afdp487

Funders

Funder type

University/education

Victor Babeș University of Medicine and Pharmacy Timișoara

No information available

Results and Publications

Intention to publish date31/12/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe dataset generated during this study will be made available upon institutional contact and reasonable request from Dr Cristina Secosan, secosan.cristina@umft.ro. These datasets will include individual patient data meta-analysis (IPD meta-analysis).

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Informed consent [English] 03/07/2023 No Yes
Participant information sheet Informed consent [Romanian] 03/07/2023 No Yes
Statistical Analysis Plan 03/07/2023 No No
Results article 22/08/2023 07/09/2023 Yes No

Additional files

43858_PIS.pdf
Informed consent [English]
43858_SAP.pdf
43858_PIS [Ro].pdf
Informed consent [Romanian]

Editorial Notes

07/09/2023: Publication reference added.
03/07/2023: Trial's existence confirmed by the Human Ethical Committee of “Victor Babes” University of Medicine and Pharmacy (Romania).